未登录

H

Herbert L. DuPont

university of texas system

H指数:106

被引数:4.2万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Microbiome alterations during and after international travel

国际旅行期间及之后的微生物组改变

JOURNAL OF TRAVEL MEDICINE

IF6.4

2025-11-010

PRE

Leaders behind the launching of the international society of travel medicine, the journal of travel medicine and helping to define a new medical discipline

国际旅行医学学会的发起人、旅行医学杂志的创办者，以及帮助定义这一新兴医学学科的先驱。

JOURNAL OF TRAVEL MEDICINE

IF6.4

2025-10-010

PRE

Re-visiting bismuth subsalicylate for the prevention of travellers' diarrhoea

重新审视水杨酸铋用于预防旅行者腹泻

JOURNAL OF TRAVEL MEDICINE

IF6.4

2025-08-011

PRE

First-Line Treatment of Fecal Microbiota Transplantation for Immune-Mediated Colitis

AMERICAN JOURNAL OF GASTROENTEROLOGY

IF7.6

2024-10-010

PRE

Fecal Transplantation Improved Patients' Reported Outcome After Immune Checkpoint Inhibitor Colitis

AMERICAN JOURNAL OF GASTROENTEROLOGY

IF7.6

2024-10-010

PRE

Microbiota restoration therapies for recurrent Clostridioides difficile infection reach an important new milestone

THERAPEUTIC ADVANCES IN GASTROENTEROLOGY

IF3.4

2024-05-242

OAAI

The potential for development of clinically relevant microbial resistance to rifaximin-α: a narrative review

CLINICAL MICROBIOLOGY REVIEWS

IF19.3

2023-12-202

OA

The Importance of a Healthy Microbiome in Pregnancy and Infancy and Microbiota Treatment to Reverse Dysbiosis for Improved Health

ANTIBIOTICS-BASEL

IF4.6

2023-11-115

OAAI

Microbiome alteration via fecal microbiota transplantation is effective for refractory immune checkpoint inhibitor-induced colitis

SCIENCE TRANSLATIONAL MEDICINE

IF14.6

2023-06-1443

PRE

IgA-Biome Profiles Correlate with Clinical Parkinson's Disease Subtypes

JOURNAL OF PARKINSONS DISEASE

IF5

2023-05-173

OAAI

Norovirus acute gastroenteritis amongst US and European travellers to areas of moderate to high risk of travellers' diarrhoea: a prospective cohort study

JOURNAL OF TRAVEL MEDICINE

IF6.4

2023-04-193

OAAI

Development of a new travellers' diarrhoea clinical severity classification and its utility in confirming rifamycin-SV efficacy

JOURNAL OF TRAVEL MEDICINE

IF6.4

2023-04-132

OAAI

Intestinal IgA-Coated Bacteria in Healthy- and Altered-Microbiomes (Dysbiosis) and Predictive Value in Successful Fecal Microbiota Transplantation

IF4.2

2022-12-299

OAAI

CLINICAL INFECTIOUS DISEASES

IF7.3

2022-07-120

PRE

Durable reduction of Clostridioides difficile infection recurrence and microbiome restoration after treatment with RBX2660: results from an open-label phase 2 clinical trial

BMC INFECTIOUS DISEASES

IF3

2022-03-1268

OAAI

Emergence of Clinical Clostridioides difficile Isolates With Decreased Susceptibility to Vancomycin

对万古霉素敏感性降低的临床艰难梭菌分离株的出现

CLINICAL INFECTIOUS DISEASES

IF7.3

2021-12-1141

OA

Potential role of probiotics in reducing Clostridioides difficile virulence: Interference with quorum sensing systems

益生菌在降低艰难梭菌毒力中的潜在作用: 干扰细胞群感应系统

MICROBIAL PATHOGENESIS

IF3.5

2021-04-0121

PREAI

Renal Impairment, C. difficile Recurrence, and the Differential Effect of Bezlotoxumab: A Post Hoc Analysis of Pooled Data From 2 Randomized Clinical Trials (vol 7, ofaa248, 2020)

OPEN FORUM INFECTIOUS DISEASES

IF3.8

2021-01-200

OAAI

Safety and efficacy of fecal microbiota transplantation to treat and prevent recurrent Clostridioides difficile in cancer patients

粪便菌群移植治疗和预防癌症患者复发艰难梭菌的安全性和有效性

JOURNAL OF CANCER

IF3.2

2021-01-019

OAAI

Renal Impairment, C. difficile Recurrence, and the Differential Effect of Bezlotoxumab: A Post Hoc Analysis of Pooled Data From 2 Randomized Clinical Trials

OPEN FORUM INFECTIOUS DISEASES

IF3.8

2020-06-266

OAAI